The observed reduction of ADORA2A protein levels in two ROHHAD individuals may be able to explain this clinical feature. The gene discussed is ADORA2A; the disease is rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome.